MedicalEd

ContinuingEd

Archived Programs

Back to Basics: Treatment Selection for Patients with Menstrual Migraine

You need to be logged in to continue.
Please Login or Register

Release Date: January 13, 2010
Expiration Date: January 13, 2011

Activity Release Date: January 13, 2010
Period of Validity: January 13, 2011

Meet the Author

Barbara J.B. Clark, MPAS, PA-C
Knox OB/GYN, Ltd.
Galesburg, Illinois

Barbara Clark is a graduate of the University of Iowa, Physician Assistant Program, and the University of Nebraska, Masters Program. She has practiced in women’s health and family practice for more than 30 years and is currently in private practice at Knox OB/GYN, Ltd. in Galesburg, Illinois. She also works as an educator, and mentors, precepts and lectures students who are in training to become physician assistants.

Barbara is past president of the Association of Physician Assistants in OB-GYN and the Illinois Academy of Physician Assistants. She currently serves the American Academy of Physician Assistants as liaison to the American College of Obstetricians and Gynecologists (ACOG) and recently served as the first physician assistant on the Board of Directors of the Association of Reproductive Health Professionals (ARHP).

Recently, Barbara was honored as the recipient of the 2009 American Academy of Physician Assistants (AAPA) PAragon Publishing Award for the article “Menstrual Migraine” which appeared in the January 2008 issue of ADVANCE magazine.

The following ACCME accredited brief is based on her award-winning paper, which was originally co-authored with Vincent T. Martin, MD.

Target Audience

This activity is designed for health care providers with an interest in the management of migraine.

Learning Objectives

After completion of this educational activity, participants will be able to:

Define goals of treatment of menstrual migraine
Differentiate approaches to treatment of menstrual migraine
Describe types of non-drug therapies which may be effective in the treatment of menstrual migraine

General Information

This activity is eligible for credit through January 13, 2011. After this date, this activity will expire and no further credit will be awarded.

There are no fees for participating in this activity. All participants must complete the Online Activity Evaluation. Participants must receive a minimum score of 70% on the self-assessment portion of the form to qualify for CE credit. Certificates may be printed immediately after completing the online self-assessment and evaluation.

This activity is supported by an educational grant from Endo Pharmaceuticals

Accreditation

CME Credit
Accreditation Statement: MediCom Worldwide, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Designation Statement: MediCom Worldwide, Inc. designates this educational activity for a maximum of .50 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

CPE Credit
MediCom Worldwide, Inc. is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is acceptable for .50 contact hour of Continuing Education Credit.
Universal Activity Number: 827-0000-10-242-H01-P. Knowledge-based CPE activity.

Disclosure

In accordance with the Accreditation Council for Continuing Medical Education (ACCME), ACPE and California Board of Nursing, MediCom Worldwide, Inc. requires that all program planners, faculty, and providers who are in a position to control the content of a CE activity are required to disclose any relevant financial relationships they may have or have had within the last 12 months with the commercial supporter or the manufacturer(s) of any commercial device(s) discussed in this educational activity. Accordingly, the following disclosures were made.

Faculty Disclosure

The presenting faculty reported the following:

Barbara Clark has disclosed that she has no significant relationships with the grantor Endo Pharmaceuticals or any other commercial company whose products and services may be related to her presentation.

Provider Disclosures

The individuals listed below from MediCom Worldwide, Inc. reported the following for this activity: Joan Meyer, executive director; Norma Jean Talley, manager, professional education; and Ruth Widmer, medical editor, have nothing to disclose.

Off-Label/Investigational Disclosures

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Further, attendees/participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program.

Ms. Clark indicated that her presentation would include the discussion of unlabeled uses of commercial products or investigational/unapproved products not yet approved by the FDA for certain uses in the United States.

Conflict of Interest Resolution

To resolve identified conflicts of interest, the educational content was fully peer reviewed by members of the MediCom Content Review Committee. The resulting certified activity was found to provide educational content that is current, evidence-based, and commercially balanced.

Americans with Disabilities Act/Special Needs

MediCom Worldwide, Inc. is committed to equality of educational opportunity and does not discriminate against applicants, students, or employees on the basis of race, color, religion, sex, national origin, age, disability, veterans status, or sexual orientation.

Hardware/Software Requirements

MediCom Worldwide, Inc. requires Internet Explorer® version 7.0 or higher, or Firefox 3.0 or higher, a computer running Windows® XP, Windows® Vista, or Mac OS X, 512MB of RAM or greater, 1.5 GHZ or faster processor, and a screen resolution of 1024x768 or higher. Certain educational activities may require additional software to view. These activities will be marked with the information and/or links to the required software. That software may be Adobe® Flash® Player, Adobe® Acrobat®, Windows Media® Player or Microsoft®Silverlight™.